Nineteen Twenty-One
Vienna venture fund backing early-stage companies in type 1 diabetes and the diseases that come with it.
🇦🇹 Vienna, Austria · Founded 2024
Nineteen Twenty-One (1921) is a venture fund in Vienna focused on type 1 diabetes and related cardiovascular, renal, neurodegenerative and metabolic disease. It was founded by Fredrik Debong, co-founder of mySugr, hi.health and Pioneers. It invests from first money in up to select Series A rounds, globally, with most of its capital going to the EU. It is an EuVECA-registered fund and works with a network of clinicians, researchers, patients and investors. The name refers to 1921, the year insulin was discovered.
Open to
- Speakers for events
Founders can book a meeting through the fund's site. The fund says an intro through shared friends helps. Fredrik Debong spoke at a Founder Institute Japan online event in February 2025.
